Circle (CRCL) Trading Analysis: A Hot IPO Gone South — Negative

CRCL   See It Market — September 05, 2025

On June 5, 2025, Circle Internet Group Inc (NASDAQ: CRCL) had its IPO. The stock price opened at $69.00 per share.

image for news Circle (CRCL) Trading Analysis: A Hot IPO Gone South

NEW YORK, Sept. 05, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Nutex Health Inc. (NASDAQ: NUTX) between August 8, 2024 and August 14, 2025, both dates inclusive (the “Class Period”), of the important October 21, 2025 lead plaintiff deadline.

image for news ROSEN, LEADING INVESTOR COUNSEL, Encourages Nutex Health Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - NUTX

Sportsman's Warehouse Q2: Still A Hairy Situation, Too Risky For Me — Negative

SPWH   Seeking Alpha — September 05, 2025

Sportsman's Warehouse Holdings, Inc. delivered mixed Q2 results, with modest sales growth on easy comps and continued margin pressure, highlighting ongoing operational challenges. The company's inability to leverage margins has led to persistent net losses, shrinking its cash runway and raising concerns about financial sustainability. Inventory and debt levels have risen significantly, increasing risk if demand softens and forcing a focus on debt repayment rather than growth initiatives.

image for news Sportsman's Warehouse Q2: Still A Hairy Situation, Too Risky For Me

York Water: I Reiterate My Buy Rating Near Multi-Year Lows — Positive

YORW   Seeking Alpha — September 05, 2025

The York Water Company's stock has given back its prior year-to-date gains, which presents another buying opportunity. The company has delivered more than 200 years of consecutive dividend payments and 29 years of dividend growth. Revenue growth is accelerating, and I expect EPS to rebound as interest rates start to decline.

image for news York Water: I Reiterate My Buy Rating Near Multi-Year Lows

The company said it added a fourth customer for its custom chips. Some analysts now think the company's AI revenue will double next year.

image for news Broadcom is starting to look ‘eerily reminiscent' of Nvidia. Both stocks are feeling the impact.

Boeing, RAAF Prove MQ-28 Operational Effectiveness — Neutral

BA   PRNewsWire — September 05, 2025

WOOMERA, South Australia , Sept. 5, 2025 /PRNewswire/ -- Boeing [NYSE: BA] and the Royal Australian Air Force (RAAF) have successfully completed demonstrations proving the operational viability of the MQ-28 Ghost Bat Collaborative Combat Aircraft (CCA).

image for news Boeing, RAAF Prove MQ-28 Operational Effectiveness

SOUTHBOROUGH, Mass.--(BUSINESS WIRE)--nirvanaHealth, the first to deploy an integrated Payer and PBM platform across all departments, announces the launch of its digital Transaction-as-a-Service (TaaS) solution on AWS designed for health plans and PBMs to substantially reduce operating costs with a digital workforce. Powered by nirvanaHealth's cloud-native Aria platform, the TaaS model enables Payers and PBMs to offload all transactional functions across the fully-insured, ASO, and PBM administ.

image for news nirvanaHealth Launches First-in-Industry Digital Transaction-as-a-Service (TaaS) Solution on AWS to Transform Payer & PBM Operations

Docusign stock higher on 2Q financial results, outlook — Positive

DOCU   Proactive Investors — September 05, 2025

Docusign, Inc. (NASDAQ: DOCU) shares gained nearly 7% to $81.23 in late-morning trading on Friday after the digital agreements and eSignatures provider's fiscal 2026 second-quarter financial results surpassed analyst expectations. Docusign reported earnings for the quarter of $0.31 per share on revenue that rose 9% year over year to $800.6 million.

image for news Docusign stock higher on 2Q financial results, outlook

Lululemon shares sink on slashed guidance, Q2 revenue miss — Negative

LULU   Proactive Investors — September 05, 2025

Lululemon Athletica Inc (NASDAQ:LULU) shares tumbled as the athletic apparel firm downwardly revised its full-year earnings guidance, citing challenges in its US business. The company now expects full-year revenue in the range of $10.85 billion to $11 billion, under the prior $11 billion to $11.1 billion range.

image for news Lululemon shares sink on slashed guidance, Q2 revenue miss

Lululemon Athletica (LULU) shares plunged Friday, after the athletic apparel retailer lowered its outlook, pointing to sluggish demand and higher tariffs.

image for news Lululemon Cuts Its Outlook as Sales Slow and Tariffs Squeeze Profits. Its Stock Is Plunging

Why Docusign Stock Is Surging Friday — Positive

DOCU   Investopedia — September 05, 2025

Docusign (DOCU) shares jumped Friday, after the maker of electronic signature software posted strong quarterly results and boosted its outlook as it added more customers and expanded its artificial intelligence offerings.

image for news Why Docusign Stock Is Surging Friday

Raymond James Welcomes New York Advisors Managing $315 Million — Neutral

RJF   GlobeNewsWire — September 05, 2025

St. Petersburg, Fla., Sept. 05, 2025 (GLOBE NEWSWIRE) -- Raymond James (NYSE: RJF) recently welcomed four financial advisors in Depew, New York, to Raymond James Financial Services (RJFS) – the firm's independent advisor channel – according to Alex David, Northeast division director for RJFS.

image for news Raymond James Welcomes New York Advisors Managing $315 Million

Bristol-Myers Squibb: Buy Before The Market Realizes Its Folly — Negative

BMY   Seeking Alpha — September 05, 2025

Bristol-Myers Squibb stock remains undervalued, even though it faces significant LOE risks through 2028. BMY's growth portfolio is gaining credence, helping to mitigate the risks due to the decline in its legacy segment. Notably, BMY's robust profitability and a sector-leading dividend yield help to secure buy-in from income investors with the patience to ride out the near-term turbulence.

image for news Bristol-Myers Squibb: Buy Before The Market Realizes Its Folly

Allan Thygesen, Docusign CEO, joins CNBC's 'Squawk on the Street' to discuss the company's most recent quarter, what industries the company is seeing the most adoption in, and much more.

image for news Docusign CEO: Quarter was powered by 'intelligent agreement management solutions' leveraging AI

NEW YORK, Sept. 05, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Neogen Corporation (NASDAQ: NEOG) between January 5, 2023 and June 3, 2025, inclusive (the “Class Period”), of the important September 16, 2025 lead plaintiff deadline.

image for news NEOG DEADLINE: ROSEN, A LEADING LAW FIRM, Encourages Neogen Corporation Investors with Losses in Excess of $100K to Secure Counsel Before Important September 16 Deadline in Securities Class Action – NEOG

KB Financial Group: An Interesting Value Play In The Financial Sector — Positive

KB   Seeking Alpha — September 05, 2025

KB Financial Group Inc. is South Korea's leading financial institution, offering strong diversification, digitalization, and growth in non-banking segments. Despite robust profitability and record earnings, KB trades at a significant discount to global peers, making it an attractive value play. The company's new capital return policy enhances shareholder value through increased dividends and aggressive share buybacks.

image for news KB Financial Group: An Interesting Value Play In The Financial Sector

ABM Industries Incorporated (ABM) Q3 2025 Earnings Call Transcript — Neutral

ABM   Seeking Alpha — September 05, 2025

ABM Industries Incorporated (NYSE:ABM ) Q3 2025 Earnings Call September 5, 2025 8:30 AM EDT Company Participants Paul Goldberg - Senior Vice President of Investor Relations Scott Salmirs - President, CEO & Director David Orr - Executive VP & CFO Conference Call Participants Benjamin Luke McFadden - William Blair & Company L.L.C., Research Division Jasper Bibb - Truist Securities, Inc., Research Division Andrew J.

image for news ABM Industries Incorporated (ABM) Q3 2025 Earnings Call Transcript

MELBOURNE, Australia, Sept. 05, 2025 (GLOBE NEWSWIRE) -- Gelteq Limited (“Gelteq” or the “Company”), a clinical and science-based company specialising in gel-based oral delivery solutions, today announced plans to commence a preclinical bioequivalence study in September 2025 to evaluate its novel gel-based formulation of a widely used antihistamine for allergy treatment.

image for news Gelteq Announces Commencement of Preclinical Trial for Novel Gel-Based Antihistamine Formulation Targeting Allergy Market

Lululemon Shares Gap Lower After Grim Outlook — Negative

LULU   Schaeffers Research — September 05, 2025

Lululemon Athletica Inc (NASDAQ:LULU) are down 18.1% to trade at $168.76 at last check, after the company topped second-quarter earnings expectations but fell short on revenue.

image for news Lululemon Shares Gap Lower After Grim Outlook

Google hit with $3.45 billion EU antitrust fine over adtech practices — Negative

GOOG  GOOGL   Reuters — September 05, 2025

Alphabet's Google was hit with a 2.95-billion-euro ($3.45 billion) EU antitrust fine on Friday for anti-competitive practices in its lucrative adtech business, marking its fourth penalty in its decade long fight with EU competition regulators.

image for news Google hit with $3.45 billion EU antitrust fine over adtech practices